{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-060502","form_type":"8-K","ticker":"BOLT","cik":"0001641281","company_name":"Bolt Biotherapeutics, Inc.","filed_at":"2021-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.440635+00:00","generated_at":"2026-06-28T00:33:57.267916+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Bolt Biotherapeutics appoints Nicole Onetto to board; Ashish Khanna resigns","bullets":["Ashish Khanna resigned from Bolt board and its Audit and Compensation committees effective Dec 13, 2021; no disagreement.","Nicole Onetto appointed as Class III director effective Dec 14, 2021; term expires at 2024 annual meeting.","Dr. Onetto received initial option grant of 27,860 shares vesting over 36 months and annual grant of 13,930 shares.","She also receives $35,000 annual cash retainer and standard indemnification; Board determined she is independent."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-060502","json":"https://secwatch.observer/filing/0001564590-21-060502.json","markdown":"https://secwatch.observer/filing/0001564590-21-060502.md","text":"https://secwatch.observer/filing/0001564590-21-060502.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641281/000156459021060502/0001564590-21-060502-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641281/000156459021060502/bolt-8k_20211213.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T00:33:57.267916+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"758c0c2cc8","claim":"Nicole Onetto was appointed as Director at Bolt Biotherapeutics, Inc..","evidence_excerpt":"On December 14, 2021, upon recommendation of the Nominating and Corporate Governance Committee, the Board appointed Nicole Onetto to the Board as a Class III director of the Company, effective immediately, to fill the vacancy on the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1641281/000156459021060502/0001564590-21-060502-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c891a03f0b","claim":"Ashish Khanna resigned as Director at Bolt Biotherapeutics, Inc..","evidence_excerpt":"On December 13, 2021, Ashish Khanna, a director of Bolt Biotherapeutics, Inc. (the “Company”) resigned as a member of the Company’s Board of Directors (the “Board”), effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1641281/000156459021060502/0001564590-21-060502-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}